Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
Earnings Data
Report Date
Mar 04, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.36Last Year’s EPS
-2Same Quarter Last Year
Moderate Sell
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in cost reductions and cash position, as well as strategic expansions and partnerships. However, these were offset by notable challenges in revenue declines and increased operating losses in the Cell Engineering segment. While the company is making strategic moves to position itself for future growth, the current financial metrics present a mixed picture.Company Guidance
Significant Cash Burn Reduction
Ginkgo achieved a dramatic reduction in quarterly cash burn over the last year, decreasing from $114 million in Q3 2024 to $28 million in Q3 2025, a 75% decrease.
Strong Cash Position
The company maintains a robust cash position with $462 million in cash and cash equivalents and no bank debt as of Q3 2025.
Expansion of Frontier Autonomous Lab
Ginkgo is expanding its frontier autonomous lab in Boston, which includes the world's largest RAC install, demonstrating advancements in AI and robotics integration.
BARDA Award
Ginkgo and its partners secured a $22 million award from BARDA for monoclonal antibody manufacturing to improve national security and reduce drug manufacturing costs.
Extended Partnership with Bayer
Ginkgo extended its 5-year partnership with Bayer to engineer microbes for fertilizer production, highlighting a long-term collaboration with a major agricultural company.
DNA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DNA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $11.30 | ― | ― |
Aug 07, 2025 | $13.46 | $12.29 | -8.69% |
May 06, 2025 | $6.45 | $7.40 | +14.73% |
Feb 25, 2025 | $10.29 | $9.11 | -11.47% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ginkgo Bioworks Holdings (DNA) report earnings?
Ginkgo Bioworks Holdings (DNA) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
What is Ginkgo Bioworks Holdings (DNA) earnings time?
Ginkgo Bioworks Holdings (DNA) earnings time is at Mar 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DNA EPS forecast?
DNA EPS forecast for the fiscal quarter 2025 (Q4) is -1.36.
